Eton Pharmaceuticals, Inc. (NASDAQ:ETON) is held by 101 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 31 Dec, 2025 | 5,720,000 | 2,860,000 | 100.00% | $96,725,200.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 2,860,000 | -2,860,000 | -50.00% | $70,584,800.00 |
| EcoR1 Capital, LLC | 31 Dec, 2025 | 2,171,938 | 141,394 | 6.96% | $53,603,430.00 |
| EcoR1 Capital, LLC | 31 Dec, 2025 | 2,030,544 | 0 | 0.00% | $34,336,499.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 1,738,907 | 34,546 | 2.03% | $29,404,917.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 1,717,286 | -21,621 | -1.24% | $42,382,617.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,348,668 | 4,553 | 0.34% | $22,805,976.00 |
| Nantahala Capital Management, LLC | 31 Dec, 2025 | 1,175,951 | 0 | 0.00% | $29,022,471.00 |
| Nantahala Capital Management, LLC | 31 Dec, 2025 | 1,175,951 | 0 | 0.00% | $19,885,331.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 994,089 | 994,089 | 0.00% | $24,534,117.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 577,666 | 12,615 | 2.23% | $14,260,695.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 565,051 | -8,979 | -1.56% | $9,557,084.00 |
| State Street Corp | 31 Dec, 2025 | 530,215 | 28,290 | 5.64% | $13,085,706.00 |
| State Street Corp | 31 Dec, 2025 | 501,925 | 63,480 | 14.48% | $8,487,552.00 |
| Morgan Stanley | 31 Dec, 2025 | 493,914 | -92,132 | -15.72% | $8,352,085.00 |
| National Philanthropic Trust | 31 Dec, 2025 | 492,112 | 0 | 0.00% | $12,145,324.00 |
| Morgan Stanley | 31 Dec, 2025 | 477,957 | -15,957 | -3.23% | $11,795,980.00 |
| Westside Investment Management, Inc. | 31 Dec, 2025 | 470,940 | -1,600 | -0.34% | $7,963,285.00 |
| Westside Investment Management, Inc. | 31 Dec, 2025 | 467,915 | -3,025 | -0.64% | $11,548,309.00 |
| OBERWEIS ASSET MANAGEMENT INC/ | 31 Dec, 2025 | 439,300 | 8,000 | 1.85% | $10,841,924.00 |